Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.
Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.
复制标题
DOI:
10.1038/sj.bjc.6602033
复制
发表时间:
2004-08-31
影响因子:
8.8
通讯作者:
中科院分区:
文献类型:
--
作者:
Proliferating cells, especially tumour cells, express a special isoenzyme of pyruvate kinase, termed M2-PK, which can occur in a tetrameric form with a high affinity to its substrate, phosphoenolpyruvate (PEP), and in a dimeric form with a low PEP affinity. In tumour cells, the dimeric form is usually predominant and is therefore termed Tumour M2-PK. The levels of Tumour M2-PK within tumours and in EDTA-plasma correlate with staging and the ability of the tumour cells to metastasise. Since most colorectal tumours grow intraluminally, it appeared interesting to determine whether Tumour M2-PK is detectable in the faeces of tumour patients. Stool samples were tested by ELISA from controls without colorectal cancer and colorectal cancer patients. Whereas Tumour M2-PK levels were low in the control group (mean value±s.e.m.: 3.3±0.4, n=144), they were high in the case of colorectal cancer (56.1±15.3, n=60). At a cutoff value of 4 U ml−1, the sensitivity was 73%. TNM and Dukes' classification of the tumours revealed a strong correlation between faecal Tumour M2-PK levels and staging. The determination of Tumour M2-PK in faeces provides a new promising screening tool for colorectal tumours.
登录
查看更多内容
影响因子:
4.8
作者:
Boren, J;Lee, WNP;Cascante, M
通讯作者:
Cascante, M
影响因子:
29.4
作者:
Ahlquist, DA;Skoletsky, JE;Shuber, AP
通讯作者:
Shuber, AP
DOI:
10.1016/s0065-2571(01)00036-x
发表时间:
2002-01-01
期刊:
ADVANCES IN ENZYME REGULATION, VOL 42, PROCEEDINGS
影响因子:
--
作者:
Le Mellay, V;Houben, R;Rapp, UR
通讯作者:
Rapp, UR
DOI:
10.1073/pnas.84.8.2251
发表时间:
1987-04-01
影响因子:
11.1
作者:
BOLEN, JB;VEILLETTE, A;ROSEN, N
通讯作者:
ROSEN, N
DOI:
10.1093/jnci/93.11.858
发表时间:
2001-06-06
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
Dong, SM;Traverso, G;Jen, J
通讯作者:
Jen, J